Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seungjin Bae

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Pharmacoeconomics|January 17, 2013
Korean guidelines for pharmacoeconomic evaluation (second and updated version) : consensus and compromiseSeungjin Bae, Soook Lee, Eun Young Bae, et al.
International Journal of Environmental Research and Public Health|September 3, 2020
The Burden of Cervical Cancer in Korea: A Population-Based StudyJinhee Kim, Donghwan Lee, Kyung-Bok Son, et al.
International Journal of Environmental Research and Public Health|December 18, 2020
A Meta-Regression Analysis of Utility Weights for Breast Cancer: The Power of Patients' ExperienceJi Ryoun Gong, Juhee Han, Donghwan Lee, et al.
Toxicological Research|October 25, 2014
Analysis of Statistical Methods Currently used in Toxicology JournalsJihye Na, Hyeri Yang, SeungJin Bae, et al.
Frontiers in Pharmacology|March 27, 2020
Marketing and Pricing Strategies of Blockbuster Drugs in the South Korean Market: A 15-Year Retrospective Cohort Study for Choline AlfoscerateJeewon Park, SeungJin Bae, Tae-Jin Lee, et al.
Frontiers in Pharmacology|September 9, 2022
Corporate social responsibility of pharmaceutical industry in KoreaGreen Bae, Jeong-Hoon Ahn, Kyung-Min Lim, et al.
Clinical Therapeutics|June 4, 2020
Are Recently Evaluated Drugs More Likely to Receive Positive Reimbursement Recommendations in South Korea? 11-year Experience of the South Korean Positive List SystemJi Ryoun Gong, Donghwan Lee, Kyung-Min Lim, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 11, 2024
Unveiling the Biosimilar Paradox of Oncologists' Perceptions and Hesitations in South Korea: A Web-Based Survey StudyGyeongseon Shin, Byung Soo Kim, Do Yeun Kim, et al.
Regulatory Toxicology and Pharmacology : RTP|July 21, 2019
Statistical analysis of the reproducibility and predictive capacity of MCTT HCE™ eye irritation test, a me-too test method for OECD TG 492Song-E Lim, Donghwan Lee, SeungJin Bae, et al.
Journal of Korean Medical Science|July 27, 2021
Should We Consider Value Frameworks for Cancer Drugs as Oncology's Landscape Evolves?; from an Oncologist Perspective in KoreaDo Yeun Kim, Hyerim Ha, SeungJin Bae, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Pharmacoeconomics|January 17, 2013
Korean guidelines for pharmacoeconomic evaluation (second and updated version) : consensus and compromiseSeungjin Bae, Soook Lee, Eun Young Bae, et al.
International Journal of Environmental Research and Public Health|September 3, 2020
The Burden of Cervical Cancer in Korea: A Population-Based StudyJinhee Kim, Donghwan Lee, Kyung-Bok Son, et al.
International Journal of Environmental Research and Public Health|December 18, 2020
A Meta-Regression Analysis of Utility Weights for Breast Cancer: The Power of Patients' ExperienceJi Ryoun Gong, Juhee Han, Donghwan Lee, et al.
Toxicological Research|October 25, 2014
Analysis of Statistical Methods Currently used in Toxicology JournalsJihye Na, Hyeri Yang, SeungJin Bae, et al.
Frontiers in Pharmacology|March 27, 2020
Marketing and Pricing Strategies of Blockbuster Drugs in the South Korean Market: A 15-Year Retrospective Cohort Study for Choline AlfoscerateJeewon Park, SeungJin Bae, Tae-Jin Lee, et al.
Frontiers in Pharmacology|September 9, 2022
Corporate social responsibility of pharmaceutical industry in KoreaGreen Bae, Jeong-Hoon Ahn, Kyung-Min Lim, et al.
Clinical Therapeutics|June 4, 2020
Are Recently Evaluated Drugs More Likely to Receive Positive Reimbursement Recommendations in South Korea? 11-year Experience of the South Korean Positive List SystemJi Ryoun Gong, Donghwan Lee, Kyung-Min Lim, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 11, 2024
Unveiling the Biosimilar Paradox of Oncologists' Perceptions and Hesitations in South Korea: A Web-Based Survey StudyGyeongseon Shin, Byung Soo Kim, Do Yeun Kim, et al.
Regulatory Toxicology and Pharmacology : RTP|July 21, 2019
Statistical analysis of the reproducibility and predictive capacity of MCTT HCE™ eye irritation test, a me-too test method for OECD TG 492Song-E Lim, Donghwan Lee, SeungJin Bae, et al.
Journal of Korean Medical Science|July 27, 2021
Should We Consider Value Frameworks for Cancer Drugs as Oncology's Landscape Evolves?; from an Oncologist Perspective in KoreaDo Yeun Kim, Hyerim Ha, SeungJin Bae, et al.
Pageof 7